Latest News
 
Identification And Biologic Significance Of Micrometastases In Axillary Lymph Nodes In Patients With Invasive Breast Cancer [July 3rd, 2009]
Access Pharmaceuticals Provides Update On Prolindac Phase 2 Ovarian Cancer Trial And Clinical Development Plan [July 3rd, 2009]
New Data Support Use Of Simple Test To Predict Endometrial Cancer Response To Chemotherapy [July 3rd, 2009]
New Colon Cancer Study Findings Have Been Published By Scientists At Arizona State University [July 3rd, 2009]
Genetic Testing For Breast Or Ovarian Cancer Risk May Be Greatly Underutilized [July 3rd, 2009]
Individuals Who Apply Pesticides Are Found To Have Double The Risk Of Blood Disorder [July 3rd, 2009]
LSU Health Sciences Center Research Finds Single Gene Controls Growth Of Some Cancers [July 3rd, 2009]
ChemGenex's Omacetaxine May Provide First Viable Treatment Option For Highly Resistant Form Of CML [July 3rd, 2009]
Dana-Farber Cancer Institute Presents Results Of Glycomimetics Lead Drug Candidate In Models Of Multiple Myeloma At American Society Of Clinical Oncology Annual Meeting [July 3rd, 2009]
New Research Shows Antidepressants May Thwart Breast Cancer Treatment [July 3rd, 2009]

We are committed to improving the treatment and understanding of cancer. Our dedicated team of professionals is committed to provide The Best Personalized Cancer Care. Our aim is to provide Complete Cancer Care and Support Services. We provide chemotherapy, infusions, support injections, vitamins, antibiotics, laboratory services among others to make it easier for our patients and their caregivers.